论文部分内容阅读
目的:探究沙利度胺联合CAG方案治疗老年急性髓系白血病临床效果。方法:选取2013年10月~2016年10月期间于本院就诊及治疗的60例老年急性髓系白血病患者作为研究对象,按照随机数字表法分为两组,每组各有30例患者,对对照组患者给予CAG方案治疗,对实验组患者给予沙利度胺联合CAG方案治疗,对比并分析两组患者的效果。结果:实验组患者的治疗总有效率(83.33%)与对照组患者(53.33%)相比,组间差异明显(p<0.05),实验组患者的恶心、呕吐例数(10例)与对照组患者(16例)相比,组间差异明显(p<0.05)。结论:对老年急性髓系白血病患者给予沙利度胺联合CAG方案治疗的效果较好。
Objective: To investigate the clinical effect of thalidomide and CAG in the treatment of senile acute myeloid leukemia. Methods: A total of 60 elderly patients with acute myeloid leukemia treated and treated in our hospital from October 2013 to October 2016 were selected and divided into two groups according to random number table: 30 patients in each group, Patients in the control group were treated with CAG regimen, and patients in the experimental group were treated with thalidomide combined with CAG regimen. The effects of both groups were compared and analyzed. Results: The total effective rate (83.33%) in the experimental group was significantly different from that in the control group (53.33%) (p <0.05). The nausea and vomiting in the experimental group (n = 10) There were significant differences between groups (p <0.05) compared with the control group (n = 16). Conclusion: Thalidomide combined with CAG regimen is effective in elderly patients with acute myeloid leukemia.